Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 300 mg powder for injection vial with diluent vial, Eli Lilly Australia Pty Ltd, CON-1219
Product name
ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 300 mg powder for injection vial with diluent vial
Sponsor name
Eli Lilly Australia Pty Ltd
Consent start
Consent no.
CON-1219
Duration
The consent is effective from 22 March 2024 until 31 March 2025.
Standard
paragraph 8 (1)(i) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The product labels do not include the current address for the sponsor, and say
North Ryde, NSW in place of Sydney, NSW
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines